ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Three‐Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas‐Kidney Transplantation in Type 1 Diabetes Patients

M. Ji1, S. Chang1, M. Wang1, K. Lentine2, M. Merzkani1, H. Murad1, M. M. Ibrahim1, M. Zayed1, J. Wellen1, S. Sutcliffe1, T. Alhamad1

1Washington University in St. Louis, Saint Louis, MO, 2Saint Louis University, Saint Louis, MO

Meeting: 2022 American Transplant Congress

Abstract number: 1150

Keywords: Kidney/pancreas transplantation, Surgery, Survival

Topic: Clinical Science » Pancreas » 65 - Pancreas and Islet: All Topics

Session Information

Session Name: Pancreas and Islet: All Topics

Session Type: Poster Abstract

Date: Sunday, June 5, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Simultaneous pancreas-kidney transplantation (SPK) is the only persistently successful treatment option for patients with diabetes mellitus and end-stage renal disease. However, SPK carries a 7-22% rate of technical failure, defined as graft loss within 3 months of transplantation. In this study, we quantified the impact of three-month pancreas graft function on kidney graft failure and patient survival following SPK in type 1 diabetic (T1DM) patients.

*Methods: We examined a national transplant registry for 22,258 T1DM patients who received transplant between 2000 and 2021 and survived the first 3 months with a functioning kidney. Transplant patients were categorized as: deceased‐donor kidney transplant alone (DDKA), living‐donor kidney transplant alone (LDKA), SPK recipients with a functioning pancreas graft 3 months posttransplant (SPK,P+), or SPK recipients with pancreas graft failure within 3 months posttransplant (SPK,P-). Associations of transplant type with kidney graft failure and patient survival through September 2021 were estimated by multivariable inverse probability of treatment weighted (IPTW) accelerated failure-time (AFT) models, with weights estimated using generalized boosted regression.

*Results: The AFT model coefficients were exponentiated to calculate time ratio (TR), 95%LCLTR95%UCL, which was interpreted as the expected time to graft failure or patient death in one category relative to the referent group. Compared to SPK,P+ recipients, LDKA had 18% less graft survival time (TR: 0.730.820.92) and 18% less patient survival time (TR: 0.720.820.93), DDKA had 23% less graft survival time (TR: 0.710.770.85) and 29% less patient survival time (TR: 0.640.710.79), and SPK,P- had 34% less graft survival time (TR: 0.590.660.75) and 34% less patient survival time (TR: 0.580.660.75).

*Conclusions: SPK recipients with functioning pancreas grafts within 3-month posttransplant have better kidney allograft and patient survival compared with LDKA and DDKA. Early pancreas graft failure results in kidney and patient survival time similar to kidney transplant alone. Our findings provide insights into the decision-making of SPK versus KA transplant options for patients and providers.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Ji M, Chang S, Wang M, Lentine K, Merzkani M, Murad H, Ibrahim MM, Zayed M, Wellen J, Sutcliffe S, Alhamad T. Three‐Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas‐Kidney Transplantation in Type 1 Diabetes Patients [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/three%e2%80%90month-pancreas-graft-function-significantly-influences-survival-following-simultaneous-pancreas%e2%80%90kidney-transplantation-in-type-1-diabetes-patients/. Accessed May 10, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences